COVID-19 | Specialty

CAR T-Cell Therapy During the COVID-19 Pandemic

April 29th 2020

TERAVOLT Data Reveal "Unexpectedly High" Mortality in Patients With Thoracic Cancers and COVID-19

April 29th 2020

Early data from TERAVOLT, a global registry collecting characteristics and outcomes of patients with thoracic cancers affected by COVID-19, suggested an unexpectedly high mortality among this patient population.

COVID-19: Practical and Immuno-Oncology Insight in Melanoma and Beyond

April 29th 2020

Paolo A. Ascierto, MD, discussed lessons he has learned from the COVID-19 crisis both in the melanoma treatment paradigm and in the broader immuno-oncology spectrum.

Adopting Multidisciplinary and Evolving Care Plans Are Essential to Treat Cancer and COVID-19

April 29th 2020

Treating patients with cancer and coronavirus disease 2019 depends upon rapidly changing assessments of the standard of care as well as considerations of comorbidities and life expectancy.

Clinical Factors Predict Deterioration Among Patients With Cancer, COVID-19

April 29th 2020

ECOG performance status, cancer type, and type of prior therapy received can predict risk for clinical worsening or death in patients with cancer who contract the coronavirus disease 2019.

Dr. Daver on Stem Cell Transplant Considerations in Hematologic Malignancies in Light of COVID-19

April 29th 2020

Naval G. Daver, MD, discusses the impact of COVID-19 on stem cell transplant for patients with hematologic malignancies and other measures put into place to prevent patients from infection.

Guiding Nurses On HCC Management During The Era Of COVID-19

April 28th 2020

Oncology Nursing and the COVID-19 Pandemic: What Nurses Need to Know

April 28th 2020

Pacritinib COVID-19 Trial Launched

April 28th 2020

Pacritinib is being explored in the phase 3 PRE-VENT trial as a treatment for cytokine storm in hospitalized patients with severe COVID-19.

Dr. Muss on the Impact of COVID-19 on Elderly Patients With Breast Cancer

April 27th 2020

Hyman B. Muss, MD, sheds light on how the COVID-19 pandemic is impacting elderly patients with breast cancer and explains why geriatric patients are at a heightened risk of developing severe complications from the virus.

Navigating COVID-19 Challenges to Provide Optimal Cancer Care

April 26th 2020

Gilberto De Lima Lopes, MD, discusses the impact of COVID-19 on his practice and how he is coping with the changes caused by the pandemic.

Desai Discusses COVID-19 Risk Among Patients With Cancer

April 24th 2020

Aakash Desai, MD, MPH. provides additional insight into his research on COVID-19 risk and patients with cancer and sheds light on how institutions are taking action against the virus.

Dr. Lopes on Providing Optimal Cancer Care Despite COVID-19

April 24th 2020

Gilberto De Lima Lopes, MD, discusses how he navigates challenges caused by COVID-19 to continue to provide optimal care to his patients with cancer.

A National Perspective on the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

April 23rd 2020

Updates and Considerations for the Multidisciplinary Management of Breast Cancer Through the COVID-19 Pandemic

April 23rd 2020

The Impact of the COVID-19 Pandemic on Laboratory and Testing Approaches

April 23rd 2020

Part 1: COVID-19 and Cancer Care: A Webinar Without Walls Lecture Series

April 23rd 2020

Adapting Cancer Medicine Is Key Part of Containing COVID-19

April 22nd 2020

Allyson Ocean, MD, explains how the outbreak has impacted treatment plans for patients, and sheds light on the work being done to develop a treatment and/or vaccine for the virus.

COVID-19 Pandemic Exposes Faults in System, But May Prompt Advances in Telehealth and Research

April 21st 2020

What was simply unimaginable just a few weeks earlier regarding the potential impact of an infectious illness in the United States on jobs, schools, the economy, and personal and family safety has become a stream of daily pronouncements about the severity of the pandemic and how best to respond.

Dr. Choueiri on the COVID-19 and Cancer Consortium

April 21st 2020

Toni K. Choueiri, MD, discusses the COVID-19 and Cancer Consortium, a multicenter effort to obtain evidence-based information on patients with cancer who have tested positive for the virus.